Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)
GlobeNewswire

Company announcement No. 46 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 36, 2026) Copenhagen, Denmark, September 7, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

seekingalpha.com - S&P Global Market Intelligence - Outsize Transaction Moves Private Equity Pharma Deals To $17.8B
Outsize Transaction Moves Private Equity Pharma Deals To $17.8B
Seeking Alpha

In July alone, the sector recorded a total transaction value of $3.74 billion, topping the second quarter's $3.21 billion. Deal volume, however, fell 11.0% year over year to 105 in the first seven months of 2026, according to Market Intelligence…

rediff.com - Nandita Malik - Stock Markets Decline: Sensex, Nifty Fall on Rising Crude Oil Prices & US-Iran Hostilities
Stock Markets Decline: Sensex, Nifty Fall on Rising Crude Oil Prices & US-Iran Hostilities
Rediff.com

Indian stock markets, including the Sensex and Nifty, experienced a downturn in early trade, primarily driven by the surge in crude oil prices and persistent geopolitical tensions stemming from US-Iran hostilities in West Asia. Indian benchmark…

swissinfo.ch - swissinfo.ch - Swiss labour market remains strong
Swiss labour market remains strong
www.swissinfo.ch

This was stated by Jérôme Cosandey, head of the labour division at the State Secretariat for Economic Affairs (SECO), while commenting via teleconference on the unemployment figures (3% in August). The only significant increase was…

thehindu.com - Pti - Stock markets decline in early trade amid rising oil prices, West Asia crisis
Stock markets decline in early trade amid rising oil prices, West Asia crisis
The Hindu

Stock market benchmark indices Sensex and Nifty declined in early trade on Tuesday (September 8, 2026) as rising crude oil prices and the U.S.-Iran hostilities kept risk appetite subdued. The 30-share BSE Sensex dropped 382.25 points to 75,750.56…

seekingalpha.com - Myriam Alvarez - PharmaMar: Expensive Multiples For Zepzelca's Growth (OTCMKTS:PHMMF)
PharmaMar: Expensive Multiples For Zepzelca's Growth (OTCMKTS:PHMMF)
Seeking Alpha

Pharma Mar is increasingly reliant on Zepzelca, even though Yondelis gives them a smaller recurring-revenue base today. Their first-line maintenance uptake is helping US royalties, while Germany and Austria give PHMMF another interesting European…

rediff.com - Nandita Malik - India White-Collar Hiring Jumps 14% in August, Led by Auto, Healthcare, Retail Sectors
India White-Collar Hiring Jumps 14% in August, Led by Auto, Healthcare, Retail Sectors
Rediff.com

India's white-collar job market witnessed a robust 14 per cent year-on-year growth in August, primarily fuelled by significant hiring increases in the auto, healthcare, and retail sectors, according to the latest Naukri JobSpeak Index. India's…

globenewswire.com - Orikine Bio - Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease
Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease
GlobeNewswire

Sabrina Kuttruff-Coqui appointed Chief Executive Officer, Joachim Koch appointed Chief Scientific and Development Officer and Andreas Muehler joining as Chief Medical Officer Expanded leadership team brings decades of expertise in translating…

thehindubusinessline.com - India should target 10 million international patients a year: Goyal
India should target 10 million international patients a year: Goyal
BusinessLine

Commerce and Industry Minister Piyush Goyal on Monday called on India's pharmaceutical and healthcare industry to build globally competitive medical devices and scale up medical value tourism, setting a target of 10 million international patients a…

cnbc.com - Elsa Ohlen - Cholesterol drug setback casts doubt over multibillion-dollar race
Cholesterol drug setback casts doubt over multibillion-dollar race
CNBC

Novartis' pelacarsen failed to reduce cardiovascular events despite lowering the harmful cholesterol Lp(a). The setback raises uncertainty for rival experimental Lp(a) drugs from Amgen and Eli Lilly. Analysts say the failure weakens, but does not…

zerohedge.com - Tyler Durden - Futures Drop As Iran Hostilities Send Brent To 6 Week High Above $97
Futures Drop As Iran Hostilities Send Brent To 6 Week High Above $97
Zero Hedge

US stock futures slipped in cautious, low volume trading as the latest Middle East escalation pushed oil prices higher, lifting bond yields in Europe and Asia. As of 9:00am ET, S&P futures were down 0.2% with Nasdaq futures modestly in the red…

thehindubusinessline.com - Gujarat cancels one drug licence, serves show-cause notices to 7 firms over illegal codeine trade
Gujarat cancels one drug licence, serves show-cause notices to 7 firms over illegal codeine trade
BusinessLine

The Gujarat State Food and Drugs Control Administration has stepped up action against the unauthorised storage, sale and misuse of codeine-containing medicines, cancelling the drug sale licence of one firm and issuing show-cause notices to seven…

irishtimes.com - Eoin Burke-Kennedy - Spike in Irish GDP triggers growth upgrade for euro zone
Spike in Irish GDP triggers growth upgrade for euro zone
The Irish Times

The euro zone economy expanded by more than originally estimated in the second quarter on the back of a sharp upward revision in Irish GDP (gross domestic product), according to Eurostat. Euro zone GDP increased 0.6 per cent, up from a preliminary…

globenewswire.com - Infex Therapeutics - Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
GlobeNewswire

Pa-positive NCFB patients experienced a significant reduction in annualised exacerbation rate from 3.4 in the prior 12 months to 1.2 on RESP-X treatment Only one exacerbation meeting the Hill/EMBARC criteria was observed across all patients dosed…

247wallst.com - Omor Ibne Ehsan - IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
24/7 Wall St

Dow Jones53,045.60−0.34% Russell 20002,966.29−0.18% Dow Jones53,045.60−0.34% Russell 20002,966.29−0.18% Dow Jones53,045.60−0.34% Russell 20002,966.29−0.18% Dow Jones53,045.60−0.34% Russell…

Receive a Daily briefing on Pharma Industry News

Get Started